Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.642 USD | -1.24% | -2.48% | -47.55% |
05-21 | Palisade Bio, Inc. Announces Presentation of Positive Preclinical Data from PALI-2108 | CI |
05-13 | Palisade Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.55% | 4.4M | |
+46.31% | 56.65B | |
-6.46% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.80% | 26.75B | |
-21.26% | 19.03B | |
+0.92% | 12.28B | |
+24.43% | 12.26B | |
+27.23% | 12.04B |
- Stock Market
- Equities
- SNCA Stock
- News Palisade Bio, Inc.
- Palisade Bio : to Sell Neurogenic Compound Previously Part of Seneca Biopharma's Product Range